| Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma S Zhao, M Choi, JD Overton, S Bellone, DM Roque, E Cocco, F Guzzo, ... Proceedings of the National Academy of Sciences 110 (8), 2916-2921, 2013 | 313 | 2013 |
| Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes AD Santin, PL Hermonat, A Ravaggi, S Bellone, S Pecorelli, JJ Roman, ... Journal of virology 74 (10), 4729-4737, 2000 | 244 | 2000 |
| Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients E Bignotti, M Ragnoli, L Zanotti, S Calza, M Falchetti, S Lonardi, ... British journal of cancer 104 (9), 1418-1425, 2011 | 228 | 2011 |
| Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ... Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016 | 205 | 2016 |
| Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type … AD Santin, PL Hermonat, A Ravaggi, M Chiriva-Internati, D Zhan, ... Journal of virology 73 (7), 5402-5410, 1999 | 205 | 1999 |
| Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial AD Santin, S Bellone, M Palmieri, A Zanolini, A Ravaggi, ER Siegel, ... Journal of virology 82 (4), 1968-1979, 2008 | 183 | 2008 |
| Secretion of vascular endothelial growth factor in ovarian cancer. AD Santin, PL Hermonat, A Ravaggi, MJ Cannon, S Pecorelli, GP Parham European journal of gynaecological oncology 20 (3), 177-181, 1999 | 167 | 1999 |
| Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management E Bandiera, C Romani, C Specchia, L Zanotti, C Galli, G Ruggeri, ... Cancer epidemiology, biomarkers & prevention 20 (12), 2496-2506, 2011 | 164 | 2011 |
| HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm G Ruggeri, E Bandiera, L Zanotti, S Belloli, A Ravaggi, C Romani, ... Clinica Chimica Acta 412 (15-16), 1447-1453, 2011 | 151 | 2011 |
| Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for … E Bignotti, RA Tassi, S Calza, A Ravaggi, C Romani, E Rossi, M Falchetti, ... Gynecologic oncology 103 (2), 405-416, 2006 | 151 | 2006 |
| Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection M Puoti, A Zonaro, A Ravaggi, MG Marin, F Castelnuovo, E Cariani Hepatology 16 (4), 877-881, 1992 | 144 | 1992 |
| Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes E Bignotti, RA Tassi, S Calza, A Ravaggi, E Bandiera, E Rossi, C Donzelli, ... American journal of obstetrics and gynecology 196 (3), 245. e1-245. e11, 2007 | 137 | 2007 |
| Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients E Bignotti, P Todeschini, S Calza, M Falchetti, M Ravanini, RA Tassi, ... European journal of cancer 46 (5), 944-953, 2010 | 136 | 2010 |
| HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study C Romagnolo, AE Leon, ASC Fabricio, M Taborelli, J Polesel, L Del Pup, ... Gynecologic oncology 141 (2), 303-311, 2016 | 133 | 2016 |
| HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities AD Santin, S Bellone, M Palmieri, A Ravaggi, C Romani, R Tassi, ... Gynecologic oncology 100 (3), 469-478, 2006 | 129 | 2006 |
| Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix AD Santin, PL Hermonat, A Ravaggi, S Bellone, J Roman, S Pecorelli, ... International Journal of Radiation Oncology* Biology* Physics 48 (4), 997-1006, 2000 | 116 | 2000 |
| Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome L Zanotti, E Bignotti, S Calza, E Bandiera, G Ruggeri, C Galli, G Tognon, ... Clinical Chemistry and Laboratory Medicine (CCLM) 50 (12), 2189-2198, 2012 | 109 | 2012 |
| Prospective study of mother‐to‐infant transmission of hepatitis C virus (HCV) infection C Mazza, A Ravaggi, A Rodella, D Padula, M Duse, M Lomini, M Puoti, ... Journal of medical virology 54 (1), 12-19, 1998 | 108 | 1998 |
| A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer ES Ratner, FK Keane, R Lindner, RA Tassi, T Paranjape, M Glasgow, ... Oncogene 31 (42), 4559-4566, 2012 | 96 | 2012 |
| Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients … AD Santin, PL Hermonat, A Ravaggi, S Bellone, JJ Roman, CV Smith, ... Gynecologic and obstetric investigation 51 (4), 254-261, 2001 | 95 | 2001 |
